
David Pirlot
Examiner (ID: 12288)
| Most Active Art Unit | 3202 |
| Art Unit(s) | 2833, 3202 |
| Total Applications | 1812 |
| Issued Applications | 1572 |
| Pending Applications | 21 |
| Abandoned Applications | 219 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 16/535279 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | Aug 7, 2019 | Abandoned |
Array
(
[id] => 15711023
[patent_doc_number] => 20200102277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => PROCESS METHODS FOR PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/533506
[patent_app_country] => US
[patent_app_date] => 2019-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16533506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/533506 | Process methods for phosphatidylinositol 3-kinase inhibitors | Aug 5, 2019 | Issued |
Array
(
[id] => 16483887
[patent_doc_number] => 20200377488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => A NOVEL COMPOUND DERIVED FROM ALLULOSE
[patent_app_type] => utility
[patent_app_number] => 16/491486
[patent_app_country] => US
[patent_app_date] => 2019-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491486 | Compound derived from allulose | Aug 1, 2019 | Issued |
Array
(
[id] => 16429433
[patent_doc_number] => 10829500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Pyridyl-triazabicycles
[patent_app_type] => utility
[patent_app_number] => 16/527307
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10941
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16527307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/527307 | Pyridyl-triazabicycles | Jul 30, 2019 | Issued |
Array
(
[id] => 15571403
[patent_doc_number] => 10576059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
[patent_app_type] => utility
[patent_app_number] => 16/521327
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9794
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16521327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/521327 | Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV | Jul 23, 2019 | Issued |
Array
(
[id] => 15880341
[patent_doc_number] => 10646493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
[patent_app_type] => utility
[patent_app_number] => 16/514749
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35996
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514749
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514749 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Jul 16, 2019 | Issued |
Array
(
[id] => 16688272
[patent_doc_number] => 20210070748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => INHIBITORS OF BRUTONS TYROSINE KINASE
[patent_app_type] => utility
[patent_app_number] => 16/514544
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 144061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16514544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/514544 | INHIBITORS OF BRUTONS TYROSINE KINASE | Jul 16, 2019 | Abandoned |
Array
(
[id] => 16198579
[patent_doc_number] => 10723729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => BACE1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/512905
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18149
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16512905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/512905 | BACE1 inhibitors | Jul 15, 2019 | Issued |
Array
(
[id] => 15086213
[patent_doc_number] => 20190337917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/513409
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16513409
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/513409 | Benzo[b]thiophene compounds as STING agonists | Jul 15, 2019 | Issued |
Array
(
[id] => 15086215
[patent_doc_number] => 20190337918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/513417
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16513417
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/513417 | Benzo[b]thiophene compounds as STING agonists | Jul 15, 2019 | Issued |
Array
(
[id] => 16222696
[patent_doc_number] => 20200247812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => HETEROCYCLIC COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/635029
[patent_app_country] => US
[patent_app_date] => 2019-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53092
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 694
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635029 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | Jul 8, 2019 | Abandoned |
Array
(
[id] => 16290068
[patent_doc_number] => 10766904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Bicyclic heteroaryl derivatives as CFTR potentiators
[patent_app_type] => utility
[patent_app_number] => 16/506883
[patent_app_country] => US
[patent_app_date] => 2019-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24585
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16506883
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/506883 | Bicyclic heteroaryl derivatives as CFTR potentiators | Jul 8, 2019 | Issued |
Array
(
[id] => 16460739
[patent_doc_number] => 10844073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Palladium-mediated ketolization
[patent_app_type] => utility
[patent_app_number] => 16/459120
[patent_app_country] => US
[patent_app_date] => 2019-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 49055
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/459120 | Palladium-mediated ketolization | Jun 30, 2019 | Issued |
Array
(
[id] => 18461463
[patent_doc_number] => 11685746
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Heteroaryl compounds for treating Huntington's disease
[patent_app_type] => utility
[patent_app_number] => 17/254848
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50749
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254848
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254848 | Heteroaryl compounds for treating Huntington's disease | Jun 24, 2019 | Issued |
Array
(
[id] => 17905493
[patent_doc_number] => 11459337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Isothiazolo[5,4-D]pyrimidine compound as IRAK4 inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/254778
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 15712
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254778 | Isothiazolo[5,4-D]pyrimidine compound as IRAK4 inhibitor | Jun 24, 2019 | Issued |
Array
(
[id] => 19564738
[patent_doc_number] => 12139499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Heteroaryl compounds for treating Huntington's disease
[patent_app_type] => utility
[patent_app_number] => 17/254828
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63562
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 479
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254828
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254828 | Heteroaryl compounds for treating Huntington's disease | Jun 24, 2019 | Issued |
Array
(
[id] => 14962937
[patent_doc_number] => 20190308946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => [6,6] FUSED BICYCLIC HDAC8 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/449675
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449675 | [6,6] fused bicyclic HDAC8 inhibitors | Jun 23, 2019 | Issued |
Array
(
[id] => 19491599
[patent_doc_number] => 12110295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/254345
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 29
[patent_no_of_words] => 94573
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254345 | WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use | Jun 20, 2019 | Issued |
Array
(
[id] => 19491599
[patent_doc_number] => 12110295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/254345
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 29
[patent_no_of_words] => 94573
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254345 | WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use | Jun 20, 2019 | Issued |
Array
(
[id] => 19491599
[patent_doc_number] => 12110295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/254345
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 29
[patent_no_of_words] => 94573
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254345 | WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use | Jun 20, 2019 | Issued |